Letter to the editor response.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 3658380)

Published in Sports Health on March 01, 2013

Authors

Matthew Matava, D Craig Brater, Nancy Gritter, Robert Heyer, Douglas Rollins, Theodore Schlegel, Robert Toto, Anthony Yates

Articles by these authors

A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med (2009) 14.13

Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med (2002) 10.52

A clone of methicillin-resistant Staphylococcus aureus among professional football players. N Engl J Med (2005) 6.14

Erythropoietic response and outcomes in kidney disease and type 2 diabetes. N Engl J Med (2010) 5.48

Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis. Ann Intern Med (2003) 5.47

Pharmacist intervention to improve medication adherence in heart failure: a randomized trial. Ann Intern Med (2007) 3.11

Proteinuria and other markers of chronic kidney disease: a position statement of the national kidney foundation (NKF) and the national institute of diabetes and digestive and kidney diseases (NIDDK). Am J Kidney Dis (2003) 2.68

The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: the RENAAL study. Kidney Int (2003) 2.43

Cardiac diseases in maintenance hemodialysis patients: results of the HEMO Study. Kidney Int (2004) 2.38

Risk scores for predicting outcomes in patients with type 2 diabetes and nephropathy: the RENAAL study. Clin J Am Soc Nephrol (2006) 2.37

Disparate estimates of hypertension control from ambulatory and clinic blood pressure measurements in hypertensive kidney disease. Hypertension (2008) 2.24

Dialysis dose and the effect of gender and body size on outcome in the HEMO Study. Kidney Int (2004) 2.16

Association between chronic kidney disease and coronary artery calcification: the Dallas Heart Study. J Am Soc Nephrol (2004) 2.08

Association between cardiac biomarkers and the development of ESRD in patients with type 2 diabetes mellitus, anemia, and CKD. Am J Kidney Dis (2011) 2.05

Preparedness of the CTSA's structural and scientific assets to support the mission of the National Center for Advancing Translational Sciences (NCATS). Clin Transl Sci (2012) 1.76

Limitations of analyses based on achieved blood pressure: lessons from the African American study of kidney disease and hypertension trial. Hypertension (2011) 1.65

A conceptual framework to study medication adherence in older adults. Am J Geriatr Pharmacother (2004) 1.54

Sustaining the Clinical and Translational Research Workforce: Training and Empowering the Next Generation of Investigators. Acad Med (2015) 1.52

Baseline characteristics of participants in the African American Study of Kidney Disease and Hypertension (AASK) Clinical Trial and Cohort Study. Am J Kidney Dis (2007) 1.50

Nephrotic syndrome after bevacizumab: case report and literature review. Am J Kidney Dis (2007) 1.46

BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy. Circulation (2002) 1.42

Hemoglobin stability in patients with anemia, CKD, and type 2 diabetes: an analysis of the TREAT (Trial to Reduce Cardiovascular Events With Aranesp Therapy) placebo arm. Am J Kidney Dis (2012) 1.38

Validation of creatinine-based estimates of GFR when evaluating risk factors in longitudinal studies of kidney disease. J Am Soc Nephrol (2006) 1.38

A comparison of iothalamate-GFR and serum creatinine-based outcomes: acceleration in the rate of GFR decline in the African American Study of Kidney Disease and Hypertension. J Am Soc Nephrol (2004) 1.37

Relationship between interdialytic weight gain and blood pressure among prevalent hemodialysis patients. Am J Kidney Dis (2007) 1.32

The rate of progression of renal disease may not be slower in women compared with men: a patient-level meta-analysis. Nephrol Dial Transplant (2003) 1.30

Urea space and total body water measurements by stable isotopes in patients with acute renal failure. Kidney Int (2004) 1.22

Loop diuretics: from the Na-K-2Cl transporter to clinical use. Am J Physiol Renal Physiol (2003) 1.20

Hypertension in diabetic nephropathy: epidemiology, mechanisms, and management. Adv Chronic Kidney Dis (2011) 1.18

Association between adherence measurements of metoprolol and health care utilization in older patients with heart failure. Clin Pharmacol Ther (2005) 1.16

Association of achieved dialysis dose with mortality in the hemodialysis study: an example of "dose-targeting bias". J Am Soc Nephrol (2005) 1.16

Intradialytic hypertension and the association with interdialytic ambulatory blood pressure. Clin J Am Soc Nephrol (2011) 1.10

Health care and medication costs and use among older adults with heart failure. Am J Med (2004) 1.06

Association between adherence to diuretic therapy and health care utilization in patients with heart failure. Pharmacotherapy (2003) 1.03

Methodology of an ongoing, randomized, controlled trial to improve drug use for elderly patients with chronic heart failure. Am J Geriatr Pharmacother (2004) 1.01

Revision ACL reconstruction outcomes: MOON cohort. J Knee Surg (2011) 1.01

Probing the mechanisms of intradialytic hypertension: a pilot study targeting endothelial cell dysfunction. Clin J Am Soc Nephrol (2012) 1.00

Baseline factors associated with congestive heart failure in patients receiving etoricoxib or diclofenac: multivariate analysis of the MEDAL program. Eur J Heart Fail (2009) 1.00

Current update in the management of diabetic nephropathy. Curr Diabetes Rev (2013) 0.98

Recommendations of the national football league physician society task force on the use of toradol(®) ketorolac in the national football league. Sports Health (2012) 0.96

Surgical site infections after arthroscopy: Outbreak investigation and case control study. Arthroscopy (2003) 0.96

Metagenome and metaproteome analyses of microbial communities in mesophilic biogas-producing anaerobic batch fermentations indicate concerted plant carbohydrate degradation. Syst Appl Microbiol (2013) 0.95

Baseline characteristics in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT). Am J Kidney Dis (2009) 0.95

Inflammation and inverse associations of body mass index and serum creatinine with mortality in hemodialysis patients. J Ren Nutr (2007) 0.93

The cost-effectiveness of single-row compared with double-row arthroscopic rotator cuff repair. J Bone Joint Surg Am (2012) 0.91

Darbepoetin alfa impact on health status in diabetes patients with kidney disease: a randomized trial. Clin J Am Soc Nephrol (2011) 0.90

Patellar tendon ruptures in National Football League players. Am J Sports Med (2011) 0.89

The MetaProteomeAnalyzer: a powerful open-source software suite for metaproteomics data analysis and interpretation. J Proteome Res (2015) 0.89

Comparative effects of non-steroidal anti-inflammatory drugs (NSAIDs) on blood pressure in patients with hypertension. BMC Cardiovasc Disord (2012) 0.88

Controversies in COX-2 selective inhibition. J Rheumatol (2002) 0.86

A trial of 2 strategies to reduce nocturnal blood pressure in blacks with chronic kidney disease. Hypertension (2012) 0.86

Metaproteome analysis to determine the metabolically active part of a thermophilic microbial community producing biogas from agricultural biomass. Can J Microbiol (2012) 0.85

Direct toxic effects of aqueous extract of cigarette smoke on cardiac myocytes at clinically relevant concentrations. Toxicol Appl Pharmacol (2009) 0.84

A randomized, double-blind, safety and tolerability study to assess the ophthalmic and renal effects of tafenoquine 200 mg weekly versus placebo for 6 months in healthy volunteers. Am J Trop Med Hyg (2009) 0.84

Systemic amyloidosis presenting as chronic diarrhea in a patient with ankylosing spondylitis. J Clin Rheumatol (2010) 0.84

A model for engaging public-private partnerships. Clin Transl Sci (2011) 0.84

Renal effects of the cyclooxygenase-inhibiting nitric oxide donator AZD3582 compared with rofecoxib and naproxen during normal and low sodium intake. Clin Pharmacol Ther (2005) 0.82

Hypertension and the kidney. Semin Nephrol (2005) 0.81

Dual blockade of the renin-angiotensin-aldosterone system: beyond the ACE inhibitor and angiotensin-II receptor blocker combination. Am J Hypertens (2009) 0.81

Indicators of cocaine exposure and preterm birth. Obstet Gynecol (2002) 0.81

Medication and dietary compliance beliefs in heart failure. West J Nurs Res (2005) 0.80

Identification and management of albuminuria in the primary care setting. J Clin Hypertens (Greenwich) (2011) 0.79

Non-contrast-enhanced computerized tomography and analgesic-related kidney disease: report of the national analgesic nephropathy study. J Am Soc Nephrol (2006) 0.79

Living kidney donation and hypertension risk. Lancet (2007) 0.79

Randomized trial of AT-1015 for treatment of intermittent claudication. A novel 5-hydroxytryptamine antagonist with no evidence of efficacy. Vasc Med (2004) 0.78

Risk of hyperkalemia associated with selective COX-2 inhibitors. Pharmacoepidemiol Drug Saf (2010) 0.78

Pharmacogenetics and healthcare outcomes in patients with chronic heart failure. Eur J Clin Pharmacol (2012) 0.77

Comparison of Ambulatory Blood Pressure Patterns in Patients With Intradialytic Hypertension and Hemodialysis Controls. Kidney Blood Press Res (2016) 0.77

Furosemide responsiveness, non-adherence and resistance during the chronic treatment of heart failure: a longitudinal study. Br J Clin Pharmacol (2004) 0.76

Factors associated with blood pressure changes in patients receiving diclofenac or etoricoxib: results from the MEDAL study. J Hypertens (2009) 0.76

Statements of Agreement From the Targeted Evaluation and Active Management (TEAM) Approaches to Treating Concussion Meeting Held in Pittsburgh, October 15-16, 2015. Neurosurgery (2016) 0.76

Blood pressure and cardiovascular outcomes in patients taking nonsteroidal antiinflammatory drugs. Cardiovasc Ther (2011) 0.75

Interdialytic ambulatory blood pressure in patients with intradialytic hypertension. Curr Opin Nephrol Hypertens (2012) 0.75

Extracellular Volume Overload and Increased Vasoconstriction in Patients With Recurrent Intradialytic Hypertension. Kidney Blood Press Res (2016) 0.75

Transition to Independence: Characteristics and Outcomes of Mentored Career Development (KL2) Scholars at Clinical and Translational Science Award Institutions. Acad Med (2017) 0.75

Future perspectives on treatment with erythropoiesis-stimulating agents in high-risk patients. NDT Plus (2009) 0.75

Application of an interferometric phase contrast method to fabricate arbitrary diffractive optical elements. Appl Opt (2008) 0.75

MPA Portable: a Stand-alone Software Package for Analyzing Metaproteome Samples on the Go. Anal Chem (2017) 0.75